Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMDW) Assets Average (2020 - 2025)

Historic Assets Average for Revolution Medicines (RVMDW) over the last 6 years, with Q3 2025 value amounting to $2.3 billion.

  • Revolution Medicines' Assets Average rose 3108.14% to $2.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year increase of 3108.14%. This contributed to the annual value of $2.3 billion for FY2024, which is 6077.22% up from last year.
  • Per Revolution Medicines' latest filing, its Assets Average stood at $2.3 billion for Q3 2025, which was up 3108.14% from $2.4 billion recorded in Q2 2025.
  • In the past 5 years, Revolution Medicines' Assets Average registered a high of $2.5 billion during Q1 2025, and its lowest value of $657.8 million during Q2 2022.
  • Moreover, its 5-year median value for Assets Average was $1.0 billion (2023), whereas its average is $1.3 billion.
  • In the last 5 years, Revolution Medicines' Assets Average crashed by 1703.48% in 2022 and then surged by 11059.37% in 2024.
  • Quarter analysis of 5 years shows Revolution Medicines' Assets Average stood at $736.5 million in 2021, then rose by 11.19% to $818.9 million in 2022, then soared by 85.97% to $1.5 billion in 2023, then soared by 41.87% to $2.2 billion in 2024, then increased by 8.34% to $2.3 billion in 2025.
  • Its last three reported values are $2.3 billion in Q3 2025, $2.4 billion for Q2 2025, and $2.5 billion during Q1 2025.